Phibro Animal Health Corporation has announced they are pursuing a patent for their developing African Swine Fever vaccine.
CEO Jack Bendheim says the group of peptides and proteins that’s
been identified is a significant step toward finding a solution to the
devastating disease.
Researchers within the company are creating an epitope-based vaccine which could treat ASF and stop the spread by creating a protective immune response in animals.
The USDA previously has given a notice of intent to license a preventative vaccine for African Swine Fever to Zoetis and a Bulgarian pharmaceutical company.
Continue reading Phibro makes progress on ASF vaccine at Brownfield Ag News.
Copyright © 2024 Indiana Farm Bureau®, Inc. is a member of the American Farm Bureau Federation®, a national organization of farmers and ranchers including Farm Bureau® organizations in 49 other states and Puerto Rico, and is responsible for Farm Bureau membership and programs within the State of Indiana.